Quick Answer
BeOne Medicines Ltd. reported Operating Income of $447.14 million for fiscal year 2025.
BeOne Medicines Ltd. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $447.14M | +178.7% |
| 2024 | -$568.20M | +53.0% |
| 2023 | -$1.21B | +32.5% |
| 2022 | -$1.79B | -24.4% |
| 2021 | -$1.44B | +13.2% |
| 2020 | -$1.66B | -72.7% |
| 2019 | -$959.89M | -36.0% |
| 2018 | -$705.77M | -616.8% |
| 2017 | -$98.46M | +15.9% |
| 2016 | -$117.06M | -106.3% |
| 2015 | -$56.74M | -260.1% |
| 2014 | -$15.76M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $163.11M | +235.6% | +85.6% |
| June 30, 2025 | $87.89M | +182.0% | +691.6% |
| March 31, 2025 | $11.10M | +104.2% | +109.2% |
| September 30, 2024 | -$120.27M | +10.2% | -12.2% |
| June 30, 2024 | -$107.16M | +66.4% | +59.0% |
| March 31, 2024 | -$261.35M | +29.6% | -95.1% |
| September 30, 2023 | -$133.97M | +69.4% | +58.0% |
| June 30, 2023 | -$318.71M | +27.5% | +14.2% |
- BeOne Medicines Ltd. showed an increase of +178.7% in Operating Income compared to the prior fiscal year.
- Over the 2014–2025 period, BeOne Medicines Ltd.’s operating income has grown by 2937.7% (from -$15.76 million to $447.14 million).
- The most recent figure is from BeOne Medicines Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: